Strattera
NDC 0002-3239, Atomoxetine hydrochloride, capsule, from Eli Lilly and Company.
- Product NDC
- 0002-3239
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021411
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-3239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOMOXETINE HYDROCHLORIDE60 mg/1
Pharmacologic classes
Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-3239-30 | 00002323930 | 30 CAPSULE in 1 BOTTLE (0002-3239-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/309de576-c318-404a-bc15-660c2b1876fb
Use it
Look up 0002-3239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-3239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-3239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.